Stuart Bloor

6.9k citations
51 papers · 5.9k · 2 hit papers · h-index 37

Impact in

  • Infectious Diseases top 0.5%
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions
  • Virology top 2%
    • HIV Research and Treatment

Papers in

Co-authors
Felix Randow (11 shared papers)Brendan A. Larder (24 shared papers)Natalia von Muhlinen (4 shared papers)Teresa L. M. Thurston (4 shared papers)Grigory Ryzhakov (3 shared papers)Kurt Hertogs (17 shared papers)Sharon D. Kemp (10 shared papers)Veronica Miller (8 shared papers)
Journals
AIDS (9 papers)Journal of Virology (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)The Journal of Infectious Diseases (3 papers)Proceedings of the National Academy of Sciences (3 papers)
Partner nations
United KingdomUnited StatesGermany

In The Last Decade

Stuart Bloor

50 papers receiving 5.6k citations

Stuart Bloor's Hit Papers

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity 2017 · 757 citations
7570+5+11Years since publication250500750
What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

  1. 2017 Nature
  2. 2009 Nature Immunology

Peers

Stuart Bloor
Comparison fields: 5 of 91
  • Infectious Diseases 2.3k
  • Virology 369
  • Epidemiology 1.1k
  • Cancer Research 393
  • Oncology 550
Replace Hans J. Zweerink with:
Hans J. Zweerink United States
Jean Rommelaere Germany
Ricardo Rajsbaum United States
Nathaniel J. Moorman United States
Mart Ustav Estonia
Matthijs Raaben Netherlands
Patrick C. Reading Australia
Cornelia Speth Austria
William M. Schneider United States
Doris Wilflingseder Austria
Stuart Bloor relative to Hans J. Zweerink United States Hans J. Zweerink's profile →
Citations per field
00.5×10×20×26×
Hans J. Zweerink · 1×
Citations per year

Countries citing papers authored by Stuart Bloor

Since Specialization
Citations

This map shows the geographic impact of Stuart Bloor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Bloor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Bloor more than expected).

Fields of papers citing papers by Stuart Bloor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Bloor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Bloor. The network helps show where Stuart Bloor may publish in the future.

Co-authors

The 25 scholars most cited alongside Stuart Bloor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stuart Bloor Line = papers co-authored together Stuart Bloor links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria
Nature Immunology ·Teresa L. M. Thurston, Grigory Ryzhakov, Stuart Bloor, Natalia von Muhlinen, Felix Randow
Hit paper breakdown →		2009757
2
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Nature ·Marian L. Burr, Christina E. Sparbier, Yih-Chih Chan, James C. Williamson, Katherine Woods, Paul A. Beavis, Enid Y.N. Lam, Melissa A. Henderson
Hit paper breakdown →		2017757
3
Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation
Cell ·Simin Rahighi, Fumiyo Ikeda, Masato Kawasaki, Masato Akutsu, Nobuhiro Suzuki, Ryuichi Kato, Tobias Kensche, Tamami Uejima
2009630
4
A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs
Antimicrobial Agents and Chemotherapy ·Kurt Hertogs, Marie‐Pierre de Béthune, Veronica Miller, Tania Ivens, Patricia Schel, Anja Van Cauwenberge, Christel Van den Eynde, Veerle Van Gerwen
1998348
5
LC3C, Bound Selectively by a Noncanonical LIR Motif in NDP52, Is Required for Antibacterial Autophagy
Molecular Cell ·Natalia von Muhlinen, Masato Akutsu, Benjamin J. Ravenhill, Ágnes Foeglein, Stuart Bloor, Trevor J. Rutherford, Stefan M.V. Freund, David Komander
2012280
6
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure
AIDS ·Veronica Miller, Caroline Anne Sabin, Kurt Hertogs, Stuart Bloor, Javier Martínez‐Picado, Richard T. D’Aquila, Brendan A. Larder, Peter Gute
2000183
7
Relative Replicative Fitness of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Isolates In Vitro
Journal of Virology ·P. Richard Harrigan, Stuart Bloor, Brendan A. Larder
1998164
8
Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples
AIDS ·Kurt Hertogs, Stuart Bloor, Sharon D. Kemp, Christel Van den Eynde, Timothy M. Alcorn, Rudi Pauwels, Margriet Van Houtte, Schlomo Staszewski
2000160
9
A Family of Insertion Mutations between Codons 67 and 70 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Multinucleoside Analog Resistance
Antimicrobial Agents and Chemotherapy ·Brendan A. Larder, Stuart Bloor, Sharon D. Kemp, Kurt Hertogs, Veronica Miller, Martin Stürmer, Schlomo Staszewski, Jingshan Ren
1999148
10
Resistance Profile of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Abacavir (1592U89) after Monotherapy and Combination Therapy
The Journal of Infectious Diseases ·P. Richard Harrigan, Phillip Griffin, Isabel Nájera, Stuart Bloor, Sharon D. Kemp, Margaret Tisdale, Brendan A. Larder +2 others
2000135
11
Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples
AIDS ·Brendan A. Larder, Kurt Hertogs, Stuart Bloor, Ch. van den Eynde, Wanda DeCian, Y.-F. Wang, William W. Freimuth, Gary Tarpley
2000124
12
Genome surveillance by HUSH-mediated silencing of intronless mobile elements
Nature ·Marta Seczyńska, Stuart Bloor, Sergio Martínez Cuesta, Paul J. Lehner
2021115
13
A Novel Polymorphism at Codon 333 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Can Facilitate Dual Resistance to Zidovudine and l -2′,3′-Dideoxy-3′-Thiacytidine
Journal of Virology ·Sharon D. Kemp, Chaofu Shi, Stuart Bloor, P. Richard Harrigan, John W. Mellors, Brendan A. Larder
1998109
14
Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility
Journal of Virology ·P. Richard Harrigan, I. Kinghorn, Stuart Bloor, Sharon D. Kemp, Isabel Nájera, Arinder Kohli, Brendan A. Larder
1996107
15
Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting
AIDS ·P. Richard Harrigan, Kurt Hertogs, Werner Verbiest, Rudi Pauwels, Brendan A. Larder, Sharon D. Kemp, Stuart Bloor, Benita Yip
1999107
16
Recruitment of TBK1 to cytosol‐invading Salmonella induces WIPI2‐dependent antibacterial autophagy
The EMBO Journal ·Teresa L. M. Thurston, Keith B. Boyle, Mark D. Allen, Benjamin J. Ravenhill, Maryia Karpiyevich, Stuart Bloor, Annie Kaul, Jessica Noad
2016107
17
Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel
AIDS ·Scott A. Wegner, Stephanie K. Brodine, John R. Mascola, Sybil A. Tasker, Richard A. Shaffer, Monica J. Starkey, Anthony J Barile, Naomi Aronson
2000104
18
A Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutational Pattern Confers Phenotypic Lamivudine Resistance in the Absence of Mutation 184V
Antimicrobial Agents and Chemotherapy ·Kurt Hertogs, Stuart Bloor, Véronique De Vroey, Christel Van den Eynde, Pascale Dehertogh, Anja Van Cauwenberge, Martin Stürmer, Timothy M. Alcorn
2000103
19
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
Nature Communications ·Matthew S Buckland, James Benjamin Galloway, Caoimhe Nic Fhogartaigh, Luke W. Meredith, Nicholas M. Provine, Stuart Bloor, Ane Ogbe, Wioleta Milena Zelek
202099
20
NDP52, a novel autophagy receptor for ubiquitin-decorated cytosolic bacteria
Autophagy ·Natalia von Muhlinen, Teresa L. M. Thurston, Grigory Ryzhako, Stuart Bloor, Felix Randow
201088

About Stuart Bloor

Stuart Bloor is a scholar working on Infectious Diseases, Virology, Epidemiology, Cancer Research and Molecular Biology, having authored 51 papers that have together received 5.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (24 papers), Autophagy in Disease and Therapy (5 papers), HIV Research and Treatment (4 papers), Epigenetics and DNA Methylation (3 papers), NF-κB Signaling Pathways (3 papers), Genomics and Chromatin Dynamics (3 papers), Heat shock proteins research (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Infectious Diseases (2.3k citations), Virology (369 citations), Epidemiology (1.1k citations), Cancer Research (393 citations) and Oncology (550 citations). Stuart Bloor has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Felix Randow, Brendan A. Larder, Natalia von Muhlinen, Teresa L. M. Thurston, Grigory Ryzhakov, Kurt Hertogs, Sharon D. Kemp, Veronica Miller, David Komander and Masato Akutsu. Their work appears in journals such as AIDS, Journal of Virology, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans J. ZweerinkBreakdown of academic impact, for papers by Jean RommelaereBreakdown of academic impact, for papers by Ricardo RajsbaumBreakdown of academic impact, for papers by Nathaniel J. MoormanBreakdown of academic impact, for papers by Mart UstavBreakdown of academic impact, for papers by Matthijs RaabenBreakdown of academic impact, for papers by Patrick C. ReadingBreakdown of academic impact, for papers by Cornelia SpethBreakdown of academic impact, for papers by William M. SchneiderBreakdown of academic impact, for papers by Doris Wilflingseder